Back
Tarsus Pharmaceuticals Stock Price Chart
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm
Buy
68
TARS
Tarsus Pharmaceuticals
Last Price:
32.15
Seasonality Move:
3.41%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TARS is experiencing buying pressure, which is a positive indicator for future bullish movement.
Tarsus Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.79 | Buy |
| 20-day SMA: | 28.19 | Buy |
| 50-day SMA: | 27.05 | Buy |
| 200-day SMA: | 28.85 | Buy |
| 8-day EMA: | 30.92 | Buy |
| 20-day EMA: | 28.96 | Buy |
| 50-day EMA: | 28.16 | Buy |
| 200-day EMA: | 27.52 | Buy |
Tarsus Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.56 | Buy |
| Relative Strength Index (14 RSI): | 68.82 | Buy |
| Chaikin Money Flow: | 556355 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.58 - 30.16) | Buy |
| Bollinger Bands (100): | (25.53 - 34.37) | Buy |
Tarsus Pharmaceuticals Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Tarsus Pharmaceuticals Stock
Is Tarsus Pharmaceuticals Stock a Buy?
- Tarsus Pharmaceuticals share price is 33.26 while TARS 8-day simple moving average is 30.79, which is a Buy signal.
- The stock price of TARS is 33.26 while Tarsus Pharmaceuticals 20-day SMA is 28.19, which makes it a Buy.
- Tarsus Pharmaceuticals 50-day simple moving average is 27.05 while TARS share price is 33.26, making it a Buy technically.
- TARS stock price is 33.26 and Tarsus Pharmaceuticals 200-day simple moving average is 28.85, creating a Buy signal.
TARS Technical Analysis vs Fundamental Analysis
Buy
68
Tarsus Pharmaceuticals (TARS)
is a Buy
Is Tarsus Pharmaceuticals a Buy or a Sell?
-
Tarsus Pharmaceuticals stock is rated a Buy
The current Tarsus Pharmaceuticals [TARS] share price is $33.26. The Score for TARS is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
Tarsus Pharmaceuticals Stock Info
Market Cap:
1.27B
Price in USD:
33.26
Share Volume:
641.42K
Tarsus Pharmaceuticals 52-Week Range
52-Week High:
42.50
52-Week Low:
12.57
Buy
68
Tarsus Pharmaceuticals (TARS)
is a Buy
Tarsus Pharmaceuticals Share Price Forecast
-
What is the Tarsus Pharmaceuticals stock price today?
The Tarsus Pharmaceuticals stock price is 33.26 USD today. -
Will TARS stock go up or go down?
Tarsus Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Tarsus Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Tarsus Pharmaceuticals is not overvalued.
Is Tarsus Pharmaceuticals Stock a Buy?
- Tarsus Pharmaceuticals share price is 33.26 while TARS 8-day exponential moving average is 30.92, which is a Buy signal.
- The stock price of TARS is 33.26 while Tarsus Pharmaceuticals 20-day EMA is 28.96, which makes it a Buy.
- Tarsus Pharmaceuticals 50-day exponential moving average is 28.16 while TARS share price is 33.26, making it a Buy technically.
- TARS stock price is 33.26 and Tarsus Pharmaceuticals 200-day simple moving average is 27.52, creating a Buy signal.
Fundamental Analysis of Tarsus Pharmaceuticals
Is Tarsus Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.21 per share, an increase this year of $0.98 per share, and an increase next year of $0.74 per share.
Technical Analysis of Tarsus Pharmaceuticals
Should I short Tarsus Pharmaceuticals stock?
- TARS Moving Average Covergence Divergence (MACD) indicator is 1.56, suggesting Tarsus Pharmaceuticals is a Buy
- Tarsus Pharmaceuticals Relative Strength Index (RSI) is 68.82, which suggest Tarsus Pharmaceuticals is overbought
- The Bollinger Bands (25) for Tarsus Pharmaceuticals is (25.58 - 30.16), which suggest Tarsus Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Tarsus Pharmaceuticals is (25.53 - 34.37), which suggest Tarsus Pharmaceuticals is a Buy
* Tarsus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.